Methyl 2-(2-(indolin-1-ylsulfonyl)-4,5-dimethoxyphenyl)acetate, 95%, 2g

Sodium 2-oxobutanoate, 5g

C-(1-Benzyl-pyrrolidin-3-yl)-methylamine, 95.0%, 10g

1-(5-Bromo-2-chlorophenyl)cyclopropan-1-ol, 98%, 1g

Methyl 5,6,7,8-tetrahydro-1,5-naphthyridine-2-carboxylate, 98%, 500mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 10 µl, 1701 RNR, 1 piece

2-Ethyl-4-methyl-1H-imidazole-5-carbaldehyde, 97.0%, 25g

2-(3-Aminopropyl)isoindoline-1,3-dione hydrochloride, 95.0%, 5g

2,2'-Oxydianiline, 98.0%, 1g

(R)-2-(Piperazin-2-yl)ethan-1-oldihydrochloride, 95%, 250mg

trans-4-Pentylcyclohexanecarboxylic acid, 97%, 100g

3-CHLORO-4-METHYL-THIOPHENE-2-CARBALDEHYDE, 95.0%, 5g

Methyl 5-bromo-1H-indole-2-carboxylate, 95.0%, 25g